US Patent 9624166 Tetracycline compounds

Patent 9624166 was granted and assigned to Tetraphase Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Tetraphase Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9624166

Patent Inventor Names

Joyce A. Sutcliffe0

Magnus P. Ronn0

Louis Plamondon0

Yonghong Deng0

Xiao-Yi Xiao0

Cuixiang Sun0

Jingye Zhou0

Date of Patent

April 18, 2017

Patent Application Number

13391407

Date Filed

August 27, 2010

Patent Primary Examiner

‌

Sabiha N. Qazi

Patent abstract

The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.